Nolan, Terry <br/><br/>
Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children.  [electronic resource] 

 -  Vaccine  Oct 2014 
 - 6146-56 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2014.08.068  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Antibodies, Viral--blood<br/>Antibody Formation<br/>Child, Preschool<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Infant<br/>Influenza A Virus, H1N1 Subtype<br/>Influenza A Virus, H3N2 Subtype<br/>Influenza B virus<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--prevention & control<br/>Male<br/>Polysorbates--administration & dosage<br/>Single-Blind Method<br/>Squalene--administration & dosage<br/>Vaccines, Subunit--administration & dosage